Global Pharmaceutical Continuous Manufacturing Market 2024-2028

List of Tables

Abstract

Pharmaceutical Continuous Manufacturing Market 2024-2028

The pharmaceutical continuous manufacturing market is forecasted to grow by USD 548.94 mn during 2023-2028, accelerating at a CAGR of 12.74% during the forecast period. The report on the pharmaceutical continuous manufacturing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

Market Scope
Base Year	2023
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	12.26%
CAGR	12.74%
Incremental Value	$548.94mn

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic diseases, evolving API manufacturing scenario in developing countries, and increasing adoption of sustainability in pharmaceutical industry.

Technavio's pharmaceutical continuous manufacturing market is segmented as below:

By Application

Final drug product manufacturing
API manufacturing

By Product

Integrated systems
Semi-continuous systems
Controls or software

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the growing digitalization and integration of industry 4.0 in continuous manufacturing as one of the prime reasons driving the pharmaceutical continuous manufacturing market growth during the next few years. Also, increasing demand for continuous manufacturing in biopharmaceutical industry and growing trend of outsourcing and contract manufacturing will lead to sizable demand in the market.

The report on the pharmaceutical continuous manufacturing market covers the following areas:

Pharmaceutical continuous manufacturing market sizing
Pharmaceutical continuous manufacturing market forecast
Pharmaceutical continuous manufacturing market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmaceutical continuous manufacturing market vendors that include Chemtrix BV, Continuus Pharmaceuticals, Coperion GmbH, Corning Inc., Dr. Helmut Rothenberger Holding GmbH, Eli Lilly and Co., Freund Vector Corp., GE Healthcare Technologies Inc., GEA Group AG, Gebruder Lodige Maschinenbau GmbH, Gericke AG, Honeywell International Inc., Hosokawa Micron Corp., Hovione, KORSCH AG, L.B. Bohle Maschinen und Verfahren GmbH, LMT Group, Novartis AG, Pfizer Inc., Siemens AG, SK Inc., Syntegon Technology GmbH, and Thermo Fisher Scientific Inc.. Also, the pharmaceutical continuous manufacturing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR76800

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global pharmaceutical continuous manufacturing market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global pharmaceutical continuous manufacturing market 2018 - 2022 ($ million)
4.2 Application Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Application Segment 2018 - 2022 ($ million)
4.3 Product Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

6.1 Market segments
Exhibit 30: Chart on Application - Market share 2023-2028 (%)
Exhibit 31: Data Table on Application - Market share 2023-2028 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Final drug product manufacturing - Market size and forecast 2023-2028
Exhibit 34: Chart on Final drug product manufacturing - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Final drug product manufacturing - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Final drug product manufacturing - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Final drug product manufacturing - Year-over-year growth 2023-2028 (%)
6.4 API manufacturing - Market size and forecast 2023-2028
Exhibit 38: Chart on API manufacturing - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on API manufacturing - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on API manufacturing - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on API manufacturing - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Application
Exhibit 42: Market opportunity by Application ($ million)
Exhibit 43: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Product

7.1 Market segments
Exhibit 44: Chart on Product - Market share 2023-2028 (%)
Exhibit 45: Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
Exhibit 46: Chart on Comparison by Product
Exhibit 47: Data Table on Comparison by Product
7.3 Integrated systems - Market size and forecast 2023-2028
Exhibit 48: Chart on Integrated systems - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Integrated systems - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Integrated systems - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Integrated systems - Year-over-year growth 2023-2028 (%)
7.4 Semi-continuous systems - Market size and forecast 2023-2028
Exhibit 52: Chart on Semi-continuous systems - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Semi-continuous systems - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Semi-continuous systems - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Semi-continuous systems - Year-over-year growth 2023-2028 (%)
7.5 Controls or software - Market size and forecast 2023-2028
Exhibit 56: Chart on Controls or software - Market size and forecast 2023-2028 ($ million)
Exhibit 57: Data Table on Controls or software - Market size and forecast 2023-2028 ($ million)
Exhibit 58: Chart on Controls or software - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Controls or software - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Product
Exhibit 60: Market opportunity by Product ($ million)
Exhibit 61: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 UK - Market size and forecast 2023-2028
Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 Coperion GmbH
Exhibit 111: Coperion GmbH - Overview
Exhibit 112: Coperion GmbH - Product / Service
Exhibit 113: Coperion GmbH - Key offerings
12.4 Corning Inc.
Exhibit 114: Corning Inc. - Overview
Exhibit 115: Corning Inc. - Business segments
Exhibit 116: Corning Inc. - Key news
Exhibit 117: Corning Inc. - Key offerings
Exhibit 118: Corning Inc. - Segment focus
12.5 Eli Lilly and Co.
Exhibit 119: Eli Lilly and Co. - Overview
Exhibit 120: Eli Lilly and Co. - Product / Service
Exhibit 121: Eli Lilly and Co. - Key news
Exhibit 122: Eli Lilly and Co. - Key offerings
12.6 GE Healthcare Technologies Inc.
Exhibit 123: GE Healthcare Technologies Inc. - Overview
Exhibit 124: GE Healthcare Technologies Inc. - Business segments
Exhibit 125: GE Healthcare Technologies Inc. - Key offerings
Exhibit 126: GE Healthcare Technologies Inc. - Segment focus
12.7 GEA Group AG
Exhibit 127: GEA Group AG - Overview
Exhibit 128: GEA Group AG - Business segments
Exhibit 129: GEA Group AG - Key offerings
Exhibit 130: GEA Group AG - Segment focus
12.8 Gebruder Lodige Maschinenbau GmbH
Exhibit 131: Gebruder Lodige Maschinenbau GmbH - Overview
Exhibit 132: Gebruder Lodige Maschinenbau GmbH - Product / Service
Exhibit 133: Gebruder Lodige Maschinenbau GmbH - Key offerings
12.9 Honeywell International Inc.
Exhibit 134: Honeywell International Inc. - Overview
Exhibit 135: Honeywell International Inc. - Business segments
Exhibit 136: Honeywell International Inc. - Key news
Exhibit 137: Honeywell International Inc. - Key offerings
Exhibit 138: Honeywell International Inc. - Segment focus
12.10 Hosokawa Micron Corp.
Exhibit 139: Hosokawa Micron Corp. - Overview
Exhibit 140: Hosokawa Micron Corp. - Business segments
Exhibit 141: Hosokawa Micron Corp. - Key offerings
Exhibit 142: Hosokawa Micron Corp. - Segment focus
12.11 L.B. Bohle Maschinen und Verfahren GmbH
Exhibit 143: L.B. Bohle Maschinen und Verfahren GmbH - Overview
Exhibit 144: L.B. Bohle Maschinen und Verfahren GmbH - Product / Service
Exhibit 145: L.B. Bohle Maschinen und Verfahren GmbH - Key offerings
12.12 Novartis AG
Exhibit 146: Novartis AG - Overview
Exhibit 147: Novartis AG - Business segments
Exhibit 148: Novartis AG - Key offerings
Exhibit 149: Novartis AG - Segment focus
12.13 Pfizer Inc.
Exhibit 150: Pfizer Inc. - Overview
Exhibit 151: Pfizer Inc. - Product / Service
Exhibit 152: Pfizer Inc. - Key news
Exhibit 153: Pfizer Inc. - Key offerings
12.14 Siemens AG
Exhibit 154: Siemens AG - Overview
Exhibit 155: Siemens AG - Business segments
Exhibit 156: Siemens AG - Key news
Exhibit 157: Siemens AG - Key offerings
Exhibit 158: Siemens AG - Segment focus
12.15 SK Inc.
Exhibit 159: SK Inc. - Overview
Exhibit 160: SK Inc. - Product / Service
Exhibit 161: SK Inc. - Key offerings
12.16 Syntegon Technology GmbH
Exhibit 162: Syntegon Technology GmbH - Overview
Exhibit 163: Syntegon Technology GmbH - Product / Service
Exhibit 164: Syntegon Technology GmbH - Key offerings
12.17 Thermo Fisher Scientific Inc.
Exhibit 165: Thermo Fisher Scientific Inc. - Overview
Exhibit 166: Thermo Fisher Scientific Inc. - Business segments
Exhibit 167: Thermo Fisher Scientific Inc. - Key news
Exhibit 168: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 169: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 170: Inclusions checklist
Exhibit 171: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 172: Currency conversion rates for US$
13.4 Research methodology
Exhibit 173: Research methodology
Exhibit 174: Validation techniques employed for market sizing
Exhibit 175: Information sources
13.5 List of abbreviations
Exhibit 176: List of abbreviations